Национальный Медицинский Университет Им. А.А. Богомольца
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Национальный Медицинский Университет Им. А.А. БогомольцаfiledCriticalНациональный Медицинский Университет Им. А.А. Богомольца
Priority to UAU201212944UpriorityCriticalpatent/UA79193U/en
Publication of UA79193UpublicationCriticalpatent/UA79193U/en
Pharmaceuticals Containing Other Organic And Inorganic Compounds
(AREA)
Abstract
A method for treating the acute ischemic stroke in the patients with metabolic syndrome provides for the use of the drugs. In the setting of the baseline therapy, Actovegin is administered intravenously by stream infusion in a volume of 5 mL daily for 10 days and Berlition is administered intravenously dropwise at a dose of 300 U in 200 mL of isotonic solution of sodium chloride daily for 10 days.
UAU201212944U2012-11-142012-11-14Method for treating acute ischemic stroke in patients with metabolic syndrome
UA79193U
(en)